New perspectives on Biotech capital formation
Published May 28, 2020
|
10 min read
RBC Capital Markets’ Vince Lozada and Tim Papp, both Managing Directors focused on biotechnology investment banking, provide perspectives on capital formation trends in the biotechnology sector.
BiotechnologyCOVID-19CoronavirusHealthcare